Vimarsana
Biggest News Aggregation in the World

Page 5 - Nasdaq Edit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Edit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Edit Today - Breaking & Trending Today

Brave Asset Management Inc. Purchases Shares of 10,725 Editas Medicine, Inc. (NASDAQ:EDIT) - Vimarsana News

Brave Asset Management Inc. Purchases Shares of 10,725 Editas Medicine, Inc. (NASDAQ:EDIT)

Brave Asset Management Inc. acquired a new position in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 10,725 shares of the company’s stock, valued at approximately $88,000. A number of other hedge funds have also modified […]

Stifel Nicolaus Upgrades Editas Medicine (NASDAQ:EDIT) to Buy - Vimarsana News

Stifel Nicolaus Upgrades Editas Medicine (NASDAQ:EDIT) to Buy

Stifel Nicolaus upgraded shares of Editas Medicine (NASDAQ:EDIT – Free Report) from a hold rating to a buy rating in a report published on Thursday morning, Marketbeat reports. They currently have $17.00 target price on the stock, up from their prior target price of $9.00. Other equities research analysts have also recently issued research reports […]

Editas Medicine (NASDAQ:EDIT) Rating Increased to Buy at Stifel Nicolaus - Vimarsana News

Editas Medicine (NASDAQ:EDIT) Rating Increased to Buy at Stifel Nicolaus

Stifel Nicolaus upgraded shares of Editas Medicine (NASDAQ:EDIT – Free Report) from a hold rating to a buy rating in a report released on Thursday morning, MarketBeat.com reports. They currently have $17.00 target price on the stock, up from their previous target price of $9.00. A number of other research analysts have also weighed in […]

Source: wkrb13.com
Editas Medicine (NASDAQ:EDIT) vs. Autolus Therapeutics (NASDAQ:AUTL) Head-To-Head Comparison - Vimarsana News

Editas Medicine (NASDAQ:EDIT) vs. Autolus Therapeutics (NASDAQ:AUTL) Head-To-Head Comparison

Editas Medicine (NASDAQ:EDIT – Get Free Report) and Autolus Therapeutics (NASDAQ:AUTL – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership. Institutional & Insider Ownership 76.6% of Editas […]

Source: wkrb13.com
125,742 Shares in Editas Medicine, Inc. (NASDAQ:EDIT) Acquired by Profund Advisors LLC - Vimarsana News

125,742 Shares in Editas Medicine, Inc. (NASDAQ:EDIT) Acquired by Profund Advisors LLC

Profund Advisors LLC purchased a new position in Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 125,742 shares of the company’s stock, valued at approximately $912,000. Profund Advisors LLC owned 0.18% of Editas Medicine at the […]